+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin label changes

Statin label changes

Medical Letter on Drugs and Therapeutics 54(1386): 21-21

(PDF emailed within 1 workday: $29.90)

Accession: 055911110

Download citation: RISBibTeXText

PMID: 22421817

Related references

Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial. Bmc Research Notes 5: 251-251, 2013

Changes to the statin label: what they really mean. Harvard Health Letter 37(7): 5-5, 2012

Persistent Use of Against-Label Statin-Fibrate Combinations from 23–29 Despite United States Food and Drug Administration Dose Restrictions. 2012

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study. Ebiomedicine 2(9): 1071-1078, 2015

Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension study. Clinical Drug Investigation 30(1): 51-61, 2010

Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions. PharmacoTherapy 32(7): 623-630, 2012

Combination of fenofibrate plus low-dose nicotinic acid added to statin treatment in type 2 diabetes: An open-label, crossover study. Current Therapeutic Research, Clinical and Experimental 67(5): 321-333, 2006

A comparison of the efficacy of combined ezetimibe and statin therapy with doubling of statin dose in patients with remnant lipoproteinemia on previous statin therapy. Journal of Cardiology 60(1): 12-17, 2013

A peri-operative statin update for non-cardiac surgery. Part I: The effects of statin therapy on atherosclerotic disease and lessons learnt from statin therapy in medical (non-surgical) patients. Anaesthesia 63(1): 52-64, 2007

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study. International Journal of Hypertension 2011: 830434-830434, 2011

Adherence to drug label recommendations for avoiding drug interactions causing statin-induced myopathy--a nationwide register study. Plos One 8(8): E69545-E69545, 2014

RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationale. Lipids in Health and Disease 12(): 142-142, 2014

Effect of high-dose statin loading on biomarkers related to inflammation and renal injury in patients hospitalized with acute heart failure. Randomized, controlled, open-label, prospective pilot study. Circulation Journal 78(10): 2447-2454, 2015

Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clinical Cardiology 37(11): 653-659, 2015

A peri-operative statin update for non-cardiac surgery. Part II: Statin therapy for vascular surgery and peri-operative statin trial design. Anaesthesia 63(2): 162-171, 2008